Madrigal Pharmaceuticals Inc. logo

Madrigal Pharmaceuticals Inc.

MDGL | NASDAQ
Chart Builder DCF Calculator
$521.96
-$9.56 (-1.80%)
At close: Sep 21, 2026, 4:00 PM ET
$521.96
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$12.28B
Enterprise Value
$11.57B
Beta
-0.99
Average Volume
330.41K
Shares Outstanding (Diluted)
29.15M
Shares Change YoY
31.24%
Institutional Ownership
81.89%
Exchange
NASDAQ
ISIN
US5588681057

Price Performance

Price Change 1M
1.0%
Price Change 3M
1.7%
Price Change 6M
13.0%
Price Change YTD
-12.1%
Price Change 1Y
18.6%
Price Change 3Y
240.4%
Price Change 5Y
514.9%
1M CAGR (ann.)
4.2%
1Y CAGR (ann.)
27.3%
5Y CAGR (ann.)
46.0%
All-Time CAGR
2.6%

Valuation

PE Ratio
-40.49
Forward PE
174.35
PEG Ratio
119.46
Forward PEG
0.20
PS Ratio
9.39
Forward PS
5.60
PB Ratio
23.03
P/FCF Ratio
-58.46
P/Adj. FCF Ratio
-39.94
P/OCF Ratio
-76.99
EV/Sales
9.01
EV/EBIT
-38.57
EV/EBITDA
-38.72
EV/FCF
-56.08
Earnings Yield
-2.5%
FCF Yield
-1.7%
Adj. FCF Yield
-2.5%

Financial Health

Net Cash
$496.93M
Total Debt
$347.75M
Cash & Short-Term Investments
$838.75M
Total Assets
$1.24B
Current Ratio
3.20
Quick Ratio
2.94
Debt / Equity Ratio
0.66
Debt / EBITDA
-1.16
Debt / FCF
-1.69
OCF / Debt
-0.57
Interest Coverage
-20.64
Altman Z-Score
8.73
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
91.5%
Operating Profit Margin
-25.1%
EBITDA Margin
-23.3%
Net Profit Margin
-25.3%
FCF Margin
-16.1%
Adj. FCF Margin
-23.5%
SBC / Revenue
7.5%
SBC Impact (per share)
-46.4%

Returns

Return on Assets
-26.1%
Return on Equity
-56.6%
Return on Invested Capital
-37.0%
Return on Capital Employed
-37.1%
Return on Tangible Assets
-26.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
105.0%
Revenue CAGR 5Y
85.0%
Revenue CAGR 10Y
50.9%
EPS CAGR 3Y
36.9%
EPS CAGR 5Y
6.0%
EPS CAGR 10Y
-15.4%
FCF CAGR 3Y
38.6%
FCF CAGR 5Y
-1.4%
FCF CAGR 10Y
-22.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
25
EPS Growth Next 3Y
133.5%
Revenue Growth Next 3Y
43.6%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$677
Price Target Upside
29.7%

Cash Flow

Operating Cash Flow
$-197.72M
Free Cash Flow
$-206.29M
Adj. Free Cash Flow
$-301.93M
FCF Per Share
-$7.08
OCF Per Share
-$6.78
OCF/S Ratio
-15.4%

Income Statement

Revenue
$1.28B
Gross Profit
$1.17B
Operating Income
$-322.62M
EBITDA
$-298.76M
Net Income
$-325.1M
EPS (Diluted)
-$12.89
Revenue / Employee
$1.4M
Profit / Employee
$-355.3K
Employees
915

© 2026 bestshares.com. All rights reserved.